Ginkgo Bioworks IPO
This company has completed its IPO and is now publicly traded (DNA).
Industry
Biotechnology
Market Cap
$800M
Total Funding
$1.6B
Headquarters
Boston, MA
View full Ginkgo Bioworks profile →